Loading...
OTCM
CNTMF
Market cap19mUSD
Dec 05, Last price  
0.04USD
1D
-0.98%
1Q
-31.65%
IPO
-97.38%
Name

Cansortium Inc

Chart & Performance

D1W1MN
OTCM:CNTMF chart
P/E
P/S
0.18
EPS
Div Yield, %
Shrs. gr., 5y
13.90%
Rev. gr., 5y
29.43%
Revenues
104m
+6.45%
008,061,00028,511,00052,388,00065,437,00087,692,00097,290,000103,562,000
Net income
-40m
L+77.54%
-1,891,763-10,135,705-327,000-53,230,000-36,735,000-19,004,000-37,146,000-22,750,000-40,390,000
CFO
2m
-90.39%
-491,640-5,056,041-12,019,000-22,680,0008,088,000-5,026,00019,069,00018,455,0001,774,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Cansortium Inc., through its subsidiaries, produces and sells medical cannabis in the United States. The company engages in the cultivation, processing, retail, and distribution activities. Its medical cannabis products are offered in oral drops, capsules, suppositories, topicals, syringes, dried flower, prerolls, cartridges, and edibles. The company provides its products under the Fluent brand name. As of August 20, 2021, it operated 28 dispensaries. Cansortium Inc. was incorporated in 2018 and is headquartered in Miami, Florida.
IPO date
Mar 21, 2019
Employees
Domiciled in
US
Incorporated in
CA

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT